Flash e-reader

 Go to e-reader chapter







Data Tables





View HTMLView PDF

Section IX

9.1aWaiting List Patient Characteristics at End of Year Liver Waiting List Active Waitlist Patients, 1999 to 2008Table 9.1a (53 k)
9.1a Age
9.1a Blood Type
9.1a Residency
9.1a Diagnosis
9.1a Gender
9.1a Previous Transplant Any Organ
9.1a Race
9.1a Patient Status
9.1a Previous Transplant Same Organ
9.1a Time on Waiting List
9.1bWaiting List Patient Characteristics at End of Year Liver Waiting List Inactive Waitlist Patients, 1999 to 2008Table 9.1b (44 k)
9.1b Age
9.1b Blood Type
9.1b Residency
9.1b Diagnosis
9.1b Gender
9.1b Previous Transplant Any Organ
9.1b Race
9.1b Previous Transplant Same Organ
9.1b Time on Waiting List
9.1cWaiting List Patient Characteristics at End of Year Liver Waiting List All Waitlist Patients, 2000 to 2009Table 9.1c (44 k)
9.1c Mean Age
9.1c Age Group
9.1c Blood Type
9.1c Residency
9.1c Diagnosis
9.1c Gender
9.1c Previous Transplant Any Organ
9.1c Race
9.1c Previous Transplant Same Organ
9.1c Time on Waiting List
9.2aEvents 7 & 15 Days After Listing 2007 and 2008 Liver Registrations with Initial Status 1Table 9.2a (21 k)
9.2bEvents 30 Days After Snapshot of Prevalent Waiting List Adult Patients on Liver Waiting List on Jan. 1, 2008Table 9.2b (38 k)
9.2b 30 Days After Snapshot
9.2b 60 Days After Snapshot
9.2b 90 Days After Snapshot
9.2cEvents 30 Days After Snapshot of Prevalent Waiting List Pediatric Patients on Liver Waiting List on Jan. 1, 2008Table 9.2c (36 k)
9.2c 30 Days After Snapshot
9.2c 60 Days After Snapshot
9.2c 90 Days After Snapshot
9.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Liver Waiting ListTable 9.3 (88 k)
9.3 Age
9.3 Blood Type
9.3 Diagnosis
9.3 Gender
9.3 Race
9.3 Patient Status
9.3 State of Center
9.4aTransplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor LiversTable 9.4a (53 k)
9.4a Age
9.4a Blood Type
9.4a Residency
9.4a Gender
9.4a Patient Status
9.4a Race
9.4a Diagnosis
9.4a Cold Ischemic Time
9.4a On Life Support at Tx
9.4a Hospitalized at Tx
9.4a Previous Transplant Same Organ
9.4a Previous Transplant Any Organ
9.4a Payment Source
9.4a Procedure Type
9.4bTransplant Recipient Characteristics, 1999 to 2008 Recipients of Living Donor LiversTable 9.4b (52 k)
9.4b Age
9.4b Blood Type
9.4b Residency
9.4b Gender
9.4b Patient Status
9.4b Race
9.4b Donor Relation
9.4b Diagnosis
9.4b On Life Support at Tx
9.4b Hospitalized at Tx
9.4b Previous Transplant Same Organ
9.4b Previous Transplant Any Organ
Payment Source
9.4cTransplant Recipient Characteristics, 2000 to 2009 Recipients of Deceased Donor LiversTable 9.4c (53 k)
9.4c Mean Age
9.4c Age Group
9.4c Blood Type
9.4c Residency
9.4c Gender
9.4c Patient Status
9.4c Race
9.4c Diagnosis
9.4c Cold Ischemic Time
9.4c On Life Support at Tx
9.4c Hospitalized at Tx
9.4c Previous Transplant Same Organ
9.4c Previous Transplant Any Organ
9.4c Payment Source
9.4c Procedure Type
9.4dTransplant Recipient Characteristics, 2000 to 2009 Recipients of Living Donor LiversTable 9.4d (52 k)
9.4d Mean Age
9.4d Age Group
9.4d Blood Type
9.4d Residency
9.4d Gender
9.4d Patient Status
9.4d Race
9.4d Donor Relation
9.4d Diagnosis
9.4d On Life Support at Tx
9.4d Hospitalized at Tx
9.4d Previous Transplant Same Organ
9.4d Previous Transplant Any Organ
9.4d Payment Source
9.5Incidence of Transplant, 1999 to 2008 Liver Transplants per 1 Million PopulationTable 9.5 (48 k)
9.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Liver TransplantsTable 9.6a (32 k)
9.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Liver TransplantsTable 9.6b (32 k)
9.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Liver TransplantsTable 9.6c (29 k)
9.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Liver TransplantsTable 9.6d (29 k)
9.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Liver TransplantsTable 9.6e (33 k)
9.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Liver TransplantsTable 9.6f (30 k)
9.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Liver TransplantsTable 9.6g (33 k)
9.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Liver TransplantsTable 9.6h (37 k)
9.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Liver TransplantsTable 9.6i (32 k)
9.7aPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Liver TransplantationTable 9.7a (126 k)
9.7a Blood Type
9.7a Residency
9.7a Gender
9.7a Patient Status
9.7a Race
9.7a Donor Age
9.7a Previous Transplant
9.7a Age
9.7a Cold Ischemic Time
9.7a On Life Support at Tx
9.7a Hospitalized at Tx
9.7a Diagnosis
9.7a State of Center
9.7bPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Living Donor Liver TransplantationTable 9.7b (105 k)
9.7b Blood Type
9.7b Residency
9.7b Gender
9.7b Patient Status
9.7b Race
9.7b Donor Age
9.7b Previous Transplant
9.7b Age
9.7b On Life Support at Tx
9.7b Hospitalized at Tx
9.7b Diagnosis
9.7b State of Center
9.8aAdjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.8a (49 k)
9.8a Age
9.8a Gender
9.8a Race
9.8a Diagnosis
9.8a State of Center
9.8bAdjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.8b (42 k)
9.8b Age
9.8b Gender
9.8b Race
9.8b Diagnosis
9.8b State of Center
9.9aAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.9a (22 k)
9.9bAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.9b (22 k)
9.10aUnadjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.10a (60 k)
9.10a Age
9.10a Blood Type
9.10a Residency
9.10a Gender
9.10a Patient Status
9.10a Race
9.10a Center Volume
9.10a Donor Age
9.10a Previous Transplant Same Organ
9.10a Diagnosis
9.10a Cold Ischemic Time
9.10a On Life Support at Tx
9.10a Hospitalized at Tx
State of Center
9.10bUnadjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.10b (54 k)
9.10b Age
9.10b Blood Type
9.10b Residency
9.10b Gender
9.10b Patient Status
9.10b Race
9.10b Center Volume
9.10b Donor Relation
9.10b Donor Age
9.10b Previous Transplant Same Organ
9.10b Diagnosis
vOn Life Support at Tx
9.10b Hospitalized at Tx
9.10b State of Center
9.11aUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.11a (22 k)
9.11bUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.11b (22 k)
9.12aAdjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.12a (49 k)
9.12a Age
9.12a Gender
9.12a Race
9.12a Diagnosis
9.12a State of Center
9.12bAdjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.12b (42 k)
9.12b Age
9.12b Gender
9.12b Race
9.12b Diagnosis
9.12b State of Center
9.13aAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.13a (22 k)
9.13bAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.13b (22 k)
9.14aUnadjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.14a (60 k)
9.14a Age
9.14a Blood Type
9.14a Residency
9.14a Gender
9.14a Patient Status
9.14a Race
9.14a Center Volume
9.14a Donor Age
9.14a Diagnosis
9.14a Cold Ischemic Time
9.14a On Life Support at Tx
9.14a Hospitalized at Tx
9.14a State of Center
9.14bUnadjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.14b (54 k)
9.14b Age
9.14b Blood Type
9.14b Residency
9.14b Gender
9.14b Patient Status
9.14b Race
9.14b Center Volume
9.14b Donor Relation
9.14b Donor Age
9.14b Diagnosis
9.14b On Life Support at Tx
9.14b Hospitalized at Tx
9.14b State of Center
9.15aUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.15a (22 k)
9.15bUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.15b (22 k)
9.16Prevalence of People Living with a Functioning Transplant at End of Year Liver Recipients, 1999 to 2007Table 9.16 (54 k)
9.16 Blood Type
9.16 Residency
9.16 Gender
9.16 Patient Status
9.16 Race
9.16 Donor Type
9.16 Age
9.16 Diagnosis
9.16 On Life Support at Tx
9.16 Hospitalized at Tx
9.16 Previous Transplant Same Organ
9.16 ssPrevious Transplant Any Organ
9.17Transplants by State and Transplant Center, 1999 to 2008 LiverTable 9.17 (70 k)